Amyloid β ( Aβ ) accumulation , mitochondrial dysfunction and oxidative stress are early steps in the pathogenesis of Alzheimer ’ s disease ( AD )

Cytosolic phospholipase A2 (cPLA2) preferentially liberates arachidonic acid (AA), which is known to be elevated in Alzheimer’s disease (AD). The aim of this study was to investigate the possible relationship between enhanced nitric oxide (NO) generation observed in AD and cPLA2 protein level, phosphorylation, and AA release in rat pheochromocytoma cell lines (PC12) differing in amyloid beta secretion. PC12 control cells, PC12 cells bearing the Swedish double mutation in amyloid beta precursor protein (APPsw), and PC12 cells transfected with human APP (APPwt) were used. The transfected APPwt and APPsw PC12 cells showed an about 2.8and 4.8-fold increase of amyloid β (Aβ) secretion comparing to control PC12 cells. An increase of NO synthase activity, cGMP and free radical levels in APPsw and APPwt PC12 cells was observed. cPLA2 protein level was higher in APPsw and APPwt PC12 cells comparing to PC12 cells. Moreover, phosphorylated cPLA2 protein level and [3H]AA release were also higher in APP-transfected PC12 cells than in the control PC12 cells. An NO donor, sodium nitroprusside, stimulated [3H]AA release from prelabeled cells. The highest NO-induced AA release was observed in control PC12 cells, the effect in the other cell lines being statistically insignificant. Inhibition of cPLA2 by AACOCF3 significantly decreased the AA release. Inhibitors of nNOS and γ-secretase reduced AA release in APPsw and APPwt PC12 cells. The basal cytosolic [Ca]i and mitochondrial Ca2+ concentration was not changed in all investigated cell lines. Stimulation with thapsigargin increased the cytosolic and mitochondrial Ca2+ level, activated NOS and stimulated AA release in APP-transfected PC12 cells. These results indicate that Aβ peptides enhance the protein level and phosphorylation of cPLA2 and AA release by the NO signaling pathway.

[1]  M. Toborek,et al.  Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons , 2006, Neuroscience.

[2]  A. Adamczyk,et al.  α-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes Relationship to nitric oxide , 2006, Neurochemistry International.

[3]  W. Müller,et al.  Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.

[4]  D. Selkoe,et al.  The ups and downs of Aβ , 2006, Nature Medicine.

[5]  Dennis Garlick,et al.  There is more to fluid intelligence than working memory capacity and executive function , 2006, Behavioral and Brain Sciences.

[6]  W. Müller,et al.  Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. , 2006, Free radical biology & medicine.

[7]  A. Eckert,et al.  Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes , 2006, Neurochemistry International.

[8]  C. Haass,et al.  Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.

[9]  D. Butterfield,et al.  Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain , 2004, Brain pathology.

[10]  C. Haass.  Take five—BACE and the γ‐secretase quartet conduct Alzheimer's amyloid β‐peptide generation , 2004 .

[11]  Á. Simonyi,et al.  Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. , 2004, Journal of lipid research.

[12]  G. J. Harry,et al.  Rat brain arachidonic acid metabolism is increased by a 6‐day intracerebral ventricular infusion of bacterial lipopolysaccharide , 2004, Journal of neurochemistry.

[13]  N. Greig,et al.  Does Nitric Oxide Synthase Contribute to the Pathogenesis of Alzheimer's Disease? , 2003, Annals of the New York Academy of Sciences.

[14]  C. Haass,et al.  Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.

[15]  G. Reiser,et al.  Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+ , 2003, British journal of pharmacology.

[16]  A. Sun,et al.  Oxidant-mediated AA release from astrocytes involves cPLA(2) and iPLA(2). , 2003, Free radical biology & medicine.

[17]  M. Vila,et al.  COX‐2 and Neurodegeneration in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[18]  Keiichiro Suzuki,et al.  Oxidative Stress Caused by Inactivation of Glutathione Peroxidase and Adaptive Responses , 2003, Biological chemistry.

[19]  C. Leslie,et al.  Inhibition of the MEK1/ERK pathway reduces arachidonic acid release independently of cPLA2 phosphorylation and translocation , 2002, BMC Biochemistry.

[20]  N. Bazan,et al.  Prostaglandins and other lipid mediators in Alzheimer's disease. , 2002, Prostaglandins & other lipid mediators.

[21]  D. Selkoe.  Presenilin, Notch, and the genesis and treatment of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Staufenbiel,et al.  Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology , 2001, Brain Research.

[23]  R. Miller,et al.  The Ca2+-sensing Receptor Activates Cytosolic Phospholipase A2 via a Gqα-dependent ERK-independent Pathway* , 2001, The Journal of Biological Chemistry.

[24]  C. Haass,et al.  Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.

[25]  K. Asayama,et al.  Induction of glutathione peroxidase in response to inactivation by nitric oxide , 2001, Free radical research.

[26]  H. Yoo,et al.  Regulation of Phospholipase D2 by H2O2 in PC12 Cells , 2000, Journal of neurochemistry.

[27]  E. Dennis,et al.  The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. , 2000, Biochimica et biophysica acta.

[28]  N. Bazan,et al.  Neuroinflammatory Signaling Upregulation in Alzheimer's Disease , 2000, Neurochemical Research.

[29]  M. Lagarde,et al.  Hydrogen peroxide activation of Ca(2+)-independent phospholipase A(2) in uterine stromal cells. , 2000, Biochemical and biophysical research communications.

[30]  C. Leslie,et al.  Cytosolic Phospholipase A2 Is Required for Macrophage Arachidonic Acid Release by Agonists That Do and Do Not Mobilize Calcium , 2000, The Journal of Biological Chemistry.

[31]  D. Flaherty,et al.  Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. , 1999, Free radical biology & medicine.

[32]  M. Rattray,et al.  Genes encoding multiple forms of phospholipase A2 are expressed in rat brain , 1998, Neuroscience Letters.

[33]  Christian Hölscher,et al.  Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis , 1998, Neurobiology of Disease.

[34]  M. Chalimoniuk,et al.  Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. , 1998, Molecular and chemical neuropathology.

[35]  M. Perkinton,et al.  Hydrogen Peroxide Enhances Signal‐Responsive Arachidonic Acid Release from Neurons: Role of Mitogen‐Activated Protein Kinase , 1998, Journal of neurochemistry.

[36]  Jeffrey C. Erlich,et al.  Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity , 1998, Journal of neurochemistry.

[37]  M. Madesh,et al.  Activation of liver mitochondrial phospholipase A2 by superoxide. , 1997, Archives of biochemistry and biophysics.

[38]  L. Horrocks,et al.  Phospholipase A2 and Its Role in Brain Tissue , 1997, Journal of neurochemistry.

[39]  J. Bonventre,et al.  Cytosolic Phospholipase A2 (PLA2), but Not Secretory PLA2, Potentiates Hydrogen Peroxide Cytotoxicity in Kidney Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[40]  D. Selkoe,et al.  Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain , 1996, Neurobiology of Disease.

[41]  H. Ischiropoulos,et al.  Evaluation of 2',7'-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. , 1993, Archives of biochemistry and biophysics.

[42]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[43]  G. Rothe,et al.  Flow Cytometric Analysis of Respiratory Burst Activity in Phagocytes With Hydroethidine and 2′,7′‐Dichlorofluorescin , 1990, Journal of leukocyte biology.

[44]  D. Shasby,et al.  Oxidants and conductance of cultured epithelial cell monolayers: inositol phospholipid hydrolysis. , 1988, The American journal of physiology.

[45]  M. Hess,et al.  PGH Synthase and Lipoxygenase Generate Superoxide in the Presence of NADH or NADPH , 1986, Circulation research.

[46]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[47]  C. Azuma,et al.  Expression of cytosolic phospholipase A2 alpha in murine C12 cells, a variant of L929 cells, induces arachidonic acid release in response to phorbol myristate acetate and Ca2+ ionophores, but not to tumor necrosis factor-alpha. , 2004, Journal of pharmacological sciences.

[48]  D. Praticò,et al.  Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[49]  D. Butterfield.  Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. , 2002, Free radical research.

[50]  Mark A. Smith,et al.  Alzheimer Disease and Oxidative Stress , 2002, Journal of Biomedicine and Biotechnology.

[51]  Á. Simonyi,et al.  Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. , 2002, Journal of neurochemistry.

[52]  R. Buchet,et al.  Alzheimer's disease: its origin at the membrane, evidence and questions. , 2000, Acta Biochimica Polonica.

[53]  T. Arendt,et al.  Nitric oxide and Alzheimer's disease. , 1998, Journal fur Hirnforschung.

[54]  G. Atsumi,et al.  Regulatory functions of phospholipase A2. , 1997, Critical reviews in immunology.

[55]  J. Bonventre,et al.  Cytosolic Phospholipase A 2 ( PLA 2 ) , but Not Secretory PLA 2 , Potentiates Hydrogen Peroxide Cytotoxicity in Kidney Epithelial Cells * , 1996 .